more rarely, near-red absorbing (Pnr) 10 . Absorption maxima vary by BphP and photochemical state 8 . Deletion of the PHY and effector domains from the BphPs of Deinococcus radiodurans (DrBphP) and Rhodopseudomonas palustris (RpBphP2) followed by extensive mutagenesis of the PAS and GAF domains resulted in the generation of several NIR FPs: IFP1.4 (excitation/emission maxima at 684 nm/708 nm) 11 , Wi-Phy (701 nm/719 nm) 12 and iRFP (692 nm/ 713 nm) 13 . IFP1.4 and iRFP were previously used for whole-body imaging 11, 13, 14 . IFP1.4 required injection of BV to become fluorescent, but iRFP efficiently incorporated endogenous BV, making iRFP as easy to use as conventional GFP-like FPs 13 . iRFP was applied for live imaging of livers 13 and tumors 14 in mice.
more rarely, near-red absorbing (Pnr) 10 . Absorption maxima vary by BphP and photochemical state 8 . Deletion of the PHY and effector domains from the BphPs of Deinococcus radiodurans (DrBphP) and Rhodopseudomonas palustris (RpBphP2) followed by extensive mutagenesis of the PAS and GAF domains resulted in the generation of several NIR FPs: IFP1.4 (excitation/emission maxima at 684 nm/708 nm) 11 , Wi-Phy (701 nm/719 nm) 12 and iRFP (692 nm/ 713 nm) 13 . IFP1.4 and iRFP were previously used for whole-body imaging 11, 13, 14 . IFP1.4 required injection of BV to become fluorescent, but iRFP efficiently incorporated endogenous BV, making iRFP as easy to use as conventional GFP-like FPs 13 . iRFP was applied for live imaging of livers 13 and tumors 14 in mice.
Having several spectrally distinct NIR FPs could open new possibilities for labeling two or more tissues or organs and for tracking several cell populations in a live animal. Here we report four NIR FPs derived from BphPs, termed iRFP670, iRFP682, iRFP702 and iRFP720 after the maxima of their emission peaks. To avoid confusion, we refer to the original iRFP as iRFP713. A palette of iRFPs enables multicolor NIR imaging in vivo.
We started from RpBphP6 (ref. 8 ) as a template for further NIR FP engineering. RpBphP6 has an absorbance maximum in the Pr state at 700 nm, 10 nm shorter than the maximum for RpBphP2 (the template for the derivation of iRFP713). First, we cut RpBphP6 to only the PAS and GAF domains, which are required to covalently incorporate BV 15 . Mutations of the invariant key residue Asp202 and the substitution Y258F (numbering follows that for RpBphP2) were shown to stabilize the chromophore in the Pr state and render the protein fluorescent 12, 16 ( Supplementary  Fig. 1 ). We performed saturated mutagenesis of the Asp202 and adjacent Ile203 positions. The brightest mutants had the substitution combination of either D202V and I203V or D202L and I203V. After three rounds of random mutagenesis, we tested the best mutants for brightness in transiently transfected HeLa cells to eliminate proteins with poor efficiency of folding and poor incorporation of BV 13 . A final variant, iRFP702, had excitation and emission maxima at 673 nm and 702 nm, respectively.
We then searched for spectrally shifted variants of iRFP713 and iRFP702 by randomly mutating them and screening the mutants using FACS, collecting mutants with blue-and red-shifted spectra in each library. Additionally, we targeted key protein positions 180, 202, 203 and 254 using saturated mutagenesis. After testing spectral properties and effective brightness in HeLa cells, we chose three final variants: iRFP670 (excitation/emission maxima at 643 nm/670 nm), iRFP682 (663 nm/682 nm) and iRFP720 (702 nm/ 720 nm) ( Table 1 and Fig. 1a,b) . Absorbance spectra (Fig. 1c) indicated that all iRFPs efficiently incorporated the BV chromophore, as the side peaks at 280 nm and 390 nm (corresponding to the absorbance of BV) are substantially smaller than the main peaks 13 . near-infrared fluorescent proteins (fPs) are in high demand for in vivo imaging. We developed four spectrally distinct near-infrared fPs-irfP670, irfP682, irfP702 and irfP720-from bacterial phytochromes. irfPs exhibit high brightness in mammalian cells and tissues and are suitable for long-term studies. irfP670 and irfP720 enable two-color imaging with standard approaches in living cells and mice. the four new irfPs and the previously engineered irfP713 allow multicolor imaging with spectral unmixing in living mice.
near-infrared fluorescent proteins for multicolor in vivo imaging
Deep optical imaging in mammalian tissues and whole mammals requires near-infrared (NIR) fluorescent probes. In the so-called NIR 'optical window' (from 650 nm to 900 nm), mammalian tissue is more transparent to light because the combined absorption of hemoglobin, melanin and water is minimal 1 . In addition, reduced autofluorescence and low light scattering make this spectral region preferable for deep-tissue imaging.
Efforts to engineer GFP-like FPs into far-red probes have resulted in several FPs shown to be useful in mammals, such as E2-Crimson 2 , mNeptune 3 , TagRFP657 (ref. 4) , eqFP650 (ref. 5) and eqFP670 (ref. 5). Among these, TagRFP657 exhibits the most red-shifted excitation maximum at 611 nm but suffers from low brightness. The photoconverted form of the photoswitchable PSmOrange 6 has an excitation peak at 634 nm; but to appear, this form requires photoconversion of the FP with blue light, which penetrates mammalian tissues poorly.
Bacterial phytochrome photoreceptors (BphPs) are promising templates for the engineering of NIR FPs 7 . Phytochromes, which are found in plants, fungi, bacteria and cyanobacteria, are a superfamily of photoreceptors that use different types of tetrapyrroles as chromophores. Members of the BphP subfamily are the most attractive source for FP development because they have the most redshifted absorption spectra among the phytochromes and because they use the chromophore biliverdin IVα (BV), which is an intermediate of heme metabolism and is ubiquitous in mammalian tissues 8, 9 . Wild-type BphPs exhibit multidomain architecture, which typically consists of the PAS, GAF, PHY and effector domains. BphPs generally adopt two spectrally different photochemical states-red absorbing (Pr) and either far-red absorbing (Pfr) or, Thus, the molecular evolution of RpBphP6-PAS-GAF and iRFP713 resulted in four new NIR FPs with absorbance and fluorescence maxima covering ~50 nm of the respective NIR ranges (Fig. 1d) .
The molecular brightness (the product of a molar extinction coefficient and quantum yield) of the new iRFP variants was similar to the brightness of iRFP713 and IFP1.4 ( Table 1) . Like the templates they are based on 11, 15 , the new iRFPs are dimeric and do not contain monomerizing mutations at the C termini of their GAF domains 11, 12 . The fluorescence of all iRFPs was stable at pH values between 4 and 8, with pK a values of 4.0 for iRFP670 and 4.5 for other iRFPs (Supplementary Fig. 2a ). To compare folding and chromophore incorporation kinetics of BphP-based FPs with those of conventional GFP-like FPs, we monitored fluorescence in bacteria upon pulse-chase induction of protein expression. All BphP-based FPs had half times (that is, time to reach half of the maximum fluorescence) for combined folding and chromophore formation comparable to that of EGFP: 4.5-5 h for iRFPs and IFP1.4 compared to 3 h for EGFP (Supplementary Fig. 2b ).
High effective brightness in mammalian cells without addition of exogenous BV is a key advantage of iRFP713 over IFP1.4. We analyzed the effective brightness of the newly developed iRFPs in transiently transfected HeLa cells. No external BV was added. The highest fluorescence signal was obtained for iRFP670 (119% of that for iRFP713); the lowest, for iRFP702 (61%) (Fig. 1e) . The effective brightness-which depends on molecular brightness, intracellular stability, affinity for BV and protein expression level-reveals that the new iRFPs could be as efficient imaging tools as iRFP713.
Epifluorescence microscopy of HeLa cells revealed evenly distributed fluorescence for all iRFPs (Supplementary Fig. 3a) . The intracellular photostability of the four iRFPs was lower than that of iRFP713 but higher than that of IFP1.4 ( Table 1 and Supplementary Fig. 3b) .
We also compared the fluorescence signal of transiently transfected HeLa cells expressing iRFP670 to the signal of cells expressing the GFP-like far-red FPs E2-Crimson, mNeptune, eqFP650 and eqFP670 (Supplementary Fig. 4 ). iRFP670 had mean fluorescence intensities sixfold higher than the intensities of these FPs, making it a promising variant for whole-cell labeling in applications involving standard red lasers.
To quantitatively compare the performance of iRFPs with that of other far-red FPs for deep-tissue imaging, we used a 'phantom' model engineered to have autofluorescence and light-scattering properties matching those of mouse muscle tissue. Equal amounts of purified FPs were placed inside the phantom at two depths (7.0 mm and 18.1 mm) and imaged in different spectral channels. We quantified the ratios of the fluorescence signal to autofluorescence background and compared the highest values for each FP among different filter channels (Fig. 1f-i) . For the most blue-shifted iRFP670, the ratios were 5.6-fold higher at 7.0 mm and 11.7-fold higher at 18.1 mm than the ratios for mNeptune at these depths. For the most red-shifted iRFP720, the ratios were 9.5-fold higher at 7.0 mm and 18.9-fold higher at 18.1 mm than the respective ratios for mNeptune.
Fluorescence stability over cell generations indicates a lack of FP cytotoxicity and is critical for the application of FPs in living animals, especially in long-term studies 17 . To test for this, we compared iRFPs with the least cytotoxic standard, EGFP 2 , in prolonged expression conditions. Preclonal mixtures of MTLn3 cells stably expressing FPs were analyzed by FACS 14 d after transfection and then 15 d after the first analysis ( Supplementary  Fig. 5a ). Cells expressing the iRFPs retained more than half of the signal at the second time point, with the largest decrease of fluorescence (to 55%) observed in iRFP702-expressing cells and the smallest (to 84%) in iRFP682-expressing cells ( Supplementary  Fig. 5b) ; cells expressing EGFP retained 74% of their initial signal. A similar analysis with other mammalian cells resulted in 24% fluorescence retention for mKate2 and 73% fluorescence retention for E2-Crimson, the least cytotoxic far-red GFP-like FP 13 .
To test the performance of iRFPs in whole-body imaging experiments, we used a mouse xenograft breast cancer model. MTLn3 cells stably expressing constructs for the different iRFPs were injected into the mammary glands of immunocompromised mice and grown into tumors. The high sensitivity of iRFPs as probes for in vivo imaging enabled detection of tumors at early stages ( Supplementary Fig. 5c ). We monitored the growth of the tumors by epifluorescence whole-body imaging for up to 4 weeks after cell injection (Supplementary Fig. 6a ). Tumors expressing iRFPs produced high NIR fluorescence signal that constantly increased, in contrast to tumors expressing EGFP, whose signal increased only at the early stages ( Supplementary Fig. 6b ). The brightness of the tumors expressing each of the iRFPs correlated with the brightness levels of the different transgenic MTLn3 lines before injection (Supplementary Fig. 6c ).
The 50-nm spectral shift between iRFP670 and iRFP720 should allow the use of these FPs in two-color imaging experiments. We quantified the fluorescence signals for each FP in two standard filter channels (excitation/emission maxima at 640 nm/680 nm and 710 nm/760 nm) (Supplementary Fig. 7a ). The imaging contrast (calculated as the ratio between fluorescence signals of one FP and another FP in the two filter channels) was 690 for the iRFP670/iRFP720 pair and 510 for the iRFP670/iRFP713 pair.
We then used the iRFPs for two-color imaging in living mice. Two tumors expressing either iRFP670 or iRFP720 were implanted simultaneously into one mouse and grown close to each other, forming the conjoined tumor. The two spatially close fluorescent tissues could be distinguished using two filter channels Ex., excitation peak; Em., emission peak; t 1/2 , photobleaching half time.
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(excitation/emission maxima at 640 nm/ 680 nm and 710 nm/760 nm) by wholebody imaging (Fig. 2a) . The same was true for two tumors of unequal sizes implanted with a time difference of 1 week ( Supplementary Fig. 7b ,c). Next we studied whether two different fluorescence sources could be spectrally separated inside an animal if they were located at different depths. Mice with a mammary gland tumor expressing iRFP670 were injected with iRFP713-encoding adenoviral particles that specifically infect mouse liver. As previously demonstrated 13 , fluorescence in the liver was detected starting at the second day after infection. Liver expressing iRFP713 and the closely located tumor expressing iRFP670 could be spectrally separated (Fig. 2b) . Using fluorescence imaging tomography, we could determine the localization of the two distinct fluorescent tissues in three dimensions (Supplementary Fig. 8 ). With ex vivo imaging of the isolated tumor and liver tissue, we confirmed iRFP670 and iRFP713 expression in these tissues (Supplementary Fig. 9 ).
To demonstrate that two-color NIR imaging is also possible with standard epifluorescence microscopy, we imaged HeLa cells expressing iRFP670 and either iRFP713 or iRFP720 in two different intracellular organelles: nucleus and mitochondria ( Fig. 2c  and Supplementary Fig. 10) .
A potentially useful application of iRFPs would be the simultaneous detection of more than two types of cells, tissues or transcription activities with spectral imaging techniques. Four types of MTLn3 cells expressing iRFP670, iRFP682, iRFP702 or iRFP720 were detected as separate populations via flow cytometry (Supplementary Fig. 11 ) and via confocal microscopy with spectral detection (Fig. 2d) . We next tested how many iRFPs we could spectrally 'unmix' in vivo using a standard whole-body imaging system with spectral detection, such as the IVIS Spectrum (PerkinElmer/Caliper). Using reference spectra for individual streaks, we distinguished five types of bacterial cells expressing iRFPs (Supplementary Fig. 12 ). In living mice, all five types of tumors also could be unmixed, starting as early as day 12 after the MTLn3 cell injection (Fig. 2e) . We confirmed the specificity of the unmixing with ex vivo imaging of the isolated tumors (Supplementary Fig. 13 ).
Further studies revealing the chromophore photochemistry responsible for the spectral shifts in iRFPs should allow researchers to design new BphP-based probes with desired spectral properties. This in turn will open the door for the engineering of biosensors to noninvasively detect metabolites and enzymatic activities in vivo. h i iR F P 6 7 0 e q F P 6 7 0 e q F P 6 5 0 m N e p t u n e E 2 -C r im s o n iR F P 6 8 2 iR F P 7 0 2 iR F P 7 1 3 iR F P 7 2 0 iR F P 6 7 0 e q F P 6 7 0 e q F P 6 5 0 m N e p t u n e E 2 -C r im s o n iR F P 6 8 2 iR F P 7 0 2 iR F P 7 1 3 iR F P 7 2 0 
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npg brief communications
Two NIR FPs engineered in this work, iRFP670 and iRFP720, are (to our knowledge) the most blue-and red-shifted BphP-based fluorescent probes reported to date. All five iRFPs have high effective brightness and low cytotoxicity and do not require exogenous BV to fluoresce in mammalian cells or in mice. The multicolor whole-body imaging techniques aided by iRFPs should become common approaches in cell and developmental biology, in studies of cancer and pathogen invasion, and in biomedicine. methods Methods and any associated references are available in the online version of the paper.
Accession codes. GenBank/EMBL/DDBJ: KC991142 (iRFP670), KC991143 (iRFP682), KC991144 (iRFP702) and KC991145 (iRFP720).
Note: Supplementary information is available in the online version of the paper. npg onLine methods Mutagenesis and screening of libraries. Internal EcoRI sites were removed from genes encoding both RpBphP6 (ref. 8) and iRFP proteins 13 using site-specific mutagenesis. A PCRamplified BglII-EcoRI fragment encoding RpBphP6 PAS-GAF domains (first 310 amino acids) was cloned into the pBAD/His-B vector (Invitrogen). Site-specific mutagenesis was performed using a QuickChange Mutagenesis Kit (Stratagene). For simultaneous mutagenesis at several positions, an overlap-extension approach was applied 18 . Random mutagenesis was performed using a GeneMorph II Random Mutagenesis Kit (Stratagene) or a Diversity PCR Random Mutagenesis Kit (Clontech) under conditions resulting in a mutation frequency of up to 16 mutations per 1,000 base pairs. After mutagenesis, a mixture of mutated genes was electroporated into LMG194 host cells (Invitrogen) containing the pWA23h plasmid facilitating biliverdin synthesis. The pWA23h plasmid contained the rhamnose promoter from the pWA21 plasmid 19 , kanamycin resistance and COLA origin parts from a pCOLADuet-1 plasmid (Novagen). First, the AvrII-PciI fragment containing kanamycin resistance and the COLA origin was PCR amplified from the pCOLADuet-1 plasmid and inserted into a pWA21h-AvrIINotI vector. Then an hmuO gene encoding Bradyrhizobium ORS278 heme oxygenase 20 was PCR amplified from the pBAD/HisB-RpBphP2-hmuO plasmid 10 and swapped with a gene encoding EGFP in the pWA21-AvrIINotI plasmid.
Typical mutant libraries consisted of about 10 6 -10 8 independent clones. The LMG194 cells were grown overnight at 37 °C in RM minimal medium supplemented with ampicillin and kanamycin. Protein expression in the libraries was induced with 0.002% arabinose and 0.02% rhamnose. The cells were grown for 6-8 h at 37 °C and then at 18 °C for 24 h. Before FACS screening, bacterial cells were washed with phosphate-buffered saline (PBS) and diluted with PBS to an optical density of 0.03 at 600 nm. The libraries were screened using MoFlo XDP (Beckman Coulter) fluorescence-activated cell sorter equipped with argon, krypton and argon-krypton mixed-gas lasers. Typically about ten sizes of each library were sorted using a 676-nm laser line for excitation and a 700-nm LP emission filter for positive selection. The brightest collected infrared bacterial cells were rescued in SOC medium at 37 °C for 1 h and then grown on LB/ampicillin/kanamycin Petri dishes supplemented with 0.02% arabinose, 0.2% rhamnose, 100 µM ALA and 50 µM FeCl 3 overnight at 37 °C and then incubated at 18 °C. To search for spectrally shifted libraries, we sorted random mutants of iRFP713 and iRFP702 with combinations of two laser lines (647 nm and 676 nm; in some experiments a 592-nm solid-state laser was used instead of 647 nm) and emission filters (670/30 nm and 718 nm LP). The dishes were analyzed with a Leica MZ16F fluorescence stereomicroscope equipped with 650/45-nm excitation and 690-nm LP emission filters (Chroma) and a CCD camera. Screening for spectrally shifted mutants on Petri dishes was performed using the IVIS Spectrum instrument (PerkinElmer/Caliper). Approximately 20-50 clones in each screen were selected. Their spectra, and their brightness in HeLa cells transfected with plasmids-obtained after the FP genes were swapped with a gene encoding EGFP in the pEGFP-N1 plasmid (Clontech)-were tested, and their DNA was sequenced. A mixture of several selected mutants was then used as a template for the next round of mutagenesis.
Protein characterization. The RpBphP6 and iRFP mutants with polyhistidine tags on the N termini were expressed in LMG194 bacterial cells grown in RM medium supplemented with ampicillin, kanamycin, 0.002% arabinose and 0.02% rhamnose for 15-18 h at 37 °C and then for 24 h at 18 °C. Proteins were purified using Ni-NTA agarose (Qiagen) according to the manufacturer's protocol with minor modification. In the wash buffer, 400 mM imidazole was substituted with 100 mM EDTA. Fluorescence spectra were recorded using a FluoroMax-3 spectrofluorometer (Jobin Yvon). A Hitachi U-2000 spectrophotometer was used for absorbance measurements.
The extinction coefficient was calculated from a comparison of absorbance values at the main peak with the absorbance value at the smaller peak at around 390 nm, assuming the latter had an extinction coefficient of free BV of 39,900 M −1 cm −1 . To determine quantum yield, we compared the fluorescence signal of a purified protein to that of an equally absorbing Nile blue dye. pH titrations were done using a series of buffers (100 mM sodium acetate, 300 mM NaCl for pH 2.5-5.0 and 100 mM NaH 2 PO 4 , 300 mM NaCl for pH 4.5-9.0).
To study protein folding and maturation in cells 21 , we grew LMG194 bacterial cells at 37 °C overnight in RM medium. The next morning, 0.2% rhamnose was added for 2 h, 0.002% arabinose was added, and cells were cultured for 1 h. Then arabinose was washed out, and cells were cultured in RM medium with 0.2% rhamnose at 37 °C. Fluorescence intensities of the equal aliquots of the cell suspension were measured at intervals after dilution to the same optical density of 0.2, and the obtained values were multiplied by the dilution factor. For EGFP expression, the procedure was the same except that the LMG194 strain did not contain the pWA21h plasmid for heme oxygenase expression.
Protein imaging in a phantom mouse. Recombinant far-red GFP-like FPs were expressed in LMG194 bacterial cells and then purified using Ni-NTA agarose (Qiagen). The purified FPs were diluted to equal concentrations of 8 µM, calculated from the extinction coefficients at the chromophore absorbance maxima. A 5-µl volume of each FP was placed 15 mm deep inside into one of two available bores in an XFM-2 phantom mouse (PerkinElmer/Caliper). The bores were located at distances of 7.0 mm and 18.1 mm from the imaging surface. Images were taken in 19 different combinations of the far-red and infrared excitation and emission channels using an epifluorescence mode of the IVIS Spectrum (PerkinElmer/Caliper). A signal-to-background ratio was calculated for each wavelength combination for each FP; the phantom mouse without protein sample inside was used as a background reference. All quantitative measurements of fluorescence signal were performed using the Living Image v.4.3.1 software (PerkinElmer/Caliper). To remove cross-bleed from the excitation light, we performed an adaptive background subtraction.
Mammalian plasmids and cell culture. The plasmids used for expression of all FPs in mammalian cells were based on pEGFP-N1 backbone (Clontech). To construct the plasmids (piRFP670-N1, piRFP682-N1, piRFP702-N1, piRFP713-N1, piRFP720-N1, pmNeptune-N1, pE2-Crimson-N1, peqFP650-N1, peqFP670-N1), we PCR-amplified the respective genes as AgeI-NotI fragments and swapped them with a gene encoding EGFP in pEGFP-N1.
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To construct pMito-iRFP670, pMito-iRFP713 and pMitoiRFP720 iRFP670, we cut iRFP713 and iRFP720 genes from N1 plasmids and swapped the with the mTagBFP gene in pMito-mTagBFP 22 . To generate pNLS-iRFP670, pNLS-iRFP713 and pNLS-iRFP720 iRFP670, we cut iRFP713 and iRFP720 genes from the piRFPs-N1 plasmids as AgeI-NotI fragments and swapped them with a gene encoding ECFP in the pNLS-ECFP plasmid.
HeLa cell lines were grown in DMEM containing 10% FBS, 0.5% penicillin-streptomycin and 2 mM glutamine (Invitrogen). For microscopy, cells were cultured in 35-mm glass-bottom culture dishes with no. 1 cover glasses (MatTek). MTLn3 rat adenocarcinoma cells were cultured in αMEM medium (Life Technologies) supplied with 5% FBS, 0.5% penicillin-streptomycin and 2 mM glutamine (Life Technologies). Plasmid transfections were performed using an Effectene reagent (Qiagen) according to the manufacturer's protocol. Stably expressing cells were selected with 700 mg/ml G418 antibiotic. Sorting of positive cells was performed using a MoFlo XDP sorter (Beckman Coulter) equipped with a 676-nm Kr laser and a 700-nm LP emission filter. Spectral imaging of mixtures of MTLn3 cells stably expressing iRFP670, iRFP682, iRFP702 and iRFP720 was performed using a Leica TCS SP5 confocal microscope (Leica Microsystems). A 63×/1.4-NA oil-immersion objective lens and a 633-nm laser line were used. Emission spectra were detected from 660 nm to 790 nm. The LAS-AF software (Leica Microsystems) was used to operate the microscope and unmix the channels. Spectra of purified FPs were used as references for unmixing. Unmixed channels were pseudocolored and overlaid using ImageJ software (NIH).
Photobleaching experiments were performed in HeLa cells transiently expressing FPs with the Olympus IX81 microscope described above. Raw data were normalized to absorbance spectra and extinction coefficients of the proteins, the spectrum of 200-W Me-Ha arc lamp and the transmission of 665/45-nm photobleaching filter.
For flow cytometry analysis of effective brightness in mammalian HeLa cells, the piRFP-N1 plasmids encoding FPs were cotransfected with pEGFP-N1 to normalize for transfection efficiency. Fluorescence intensity of cells was analyzed using either a LSRII cytometer (BD Biosciences) equipped with 488-nm and 635-nm lasers and using 530/30-nm, 660/20-nm, 710/20-nm and 780/60-nm filters or the similar LSRII cytometer (BD Biosciences) equipped with 488-nm and 640-lasers and using 525/30-nm, 670/30-nm, 730/45-nm and 780/60-nm filters.
For cell fluorescence quantification, a mean fluorescence intensity of the non-negative population in the near-infrared channel was divided by a mean fluorescence intensity of the same population in the green channel, thus normalizing the near-infrared signal to the transfection efficiency. All FACS calculations were performed using FlowJo software (Tree Star).
Cytotoxicity was estimated as a stability of fluorescence over cell generations as described before 13 . MTLn3 cells were transfected with plasmids encoding iRFP670, iRFP682, iRFP702, iRFP713, iRFP720 and EGFP. After several days, the drug G418 was added to a final concentration of 700 µg/ml to select for stable preclonal mixtures. On day 14 post-transfection the cells were sorted using the MoFlo XDP cell sorter, and the brightest fluorescent population for each protein was collected. An aliquot of collected cells was analyzed the same day using the LSRII cytometer (10,000 events). After 15 more days of culturing in the presence of G418 (29 d after transfection in total), the cells were analyzed using the LSRII cytometer in the same conditions. Histograms representing cell populations and mean fluorescence intensities of the sorted cells were obtained using FlowJo.
Discrimination of four types of MTLn3 cells stably expressing iRFP670, iRFP682, iRFP702 and iRFP720 (with a single FP type per cell) was performed using the LSRII cytometer with the 635-nm laser and 660/20-nm and 780/60-nm emission filters. Events (10,000) for each cell type were analyzed under the same conditions in one experiment. The obtained dot plots were superimposed.
Construction of adenoviral vectors.
The adenovirus serotype V-based particles 23 containing the iRFP were obtained using an AdEasy XL Adenoviral Vector System (Stratagene), as described 13 .
In vivo imaging. To implant xenograph tumors, 10 6 MTLn3 cells stably expressing iRFP670, iRFP682, iRFP702, iRFP713, iRFP720 or EGFP (with a single FP type per cell) were injected into the mammary gland of SCID/NCr mice (female, 5-7 weeks old) (Taconic) and imaged starting 1 week later using the IVIS Spectrum in epifluorescence mode. All mice were imaged in 19 filter channels using the IVIS Spectrum. Belly fur was removed using a depilatory cream. Mice were fed with AIN-93M Maintenance Purified Diet (TestDiet) to reduce the intrinsic autofluorescence level. All quantitative measurements of fluorescence signal were made with Living Image.
For fluorescence time-course measurement, mice with a single tumor were imaged over 4 weeks after cell injection. Backgroundsubtracted images of total radiant efficiencies of the same region over tumors were generated. Filter channels used for calculation of tumor growth curves were the following: 640/30-nm exciter and 680/20-nm emitter for iRFP670; 675/30-nm exciter and 720/20-nm emitter for iRFP682, iRFP702, iRFP713; and 710/30-nm exciter and 710/760-nm emitter for iRFP720.
For two-color imaging of two tumors, mice were injected with MTLn3 cells expressing either iRFP670 or iRFP720 in close sites the same day or with a time difference of 1 week. For two-color imaging of iRFP670-expressing tumor and iRFP713-expressing liver, mice with a xenograph tumor expressing iRFP670 were intravenously injected with 2 × 10 9 infectious units of an adenovirus at day 18 or 24 after MTLn3 cell injection.
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For spectral imaging of five FPs, mice were injected with two types of MTLn3 cells each on the same day. For spectral unmixing, an image cube was collected on the IVIS Spectrum with 19 filter channels. Fluorescence regions were identified and spectrally unmixed using Living Image. Spectral data obtained for individual bacterial streaks expressing iRFP670, iRFP682, iRFP702, iRFP713 or iRFP720 were used as references for unmixing.
For fluorescence imaging tomography (FLIT), mice were depilated, and images were taken in transillumination mode. Data acquisition and processing were performed according to the Living Image v.4.3.1 protocol. Two fluorescence samples were imaged with different filter sets (640/30-nm exciter and 680/20-nm emitter for iRFP670, 710/30-nm exciter and 710/60-nm emitter for iRFP713) and then overlaid.
The tumors and livers were excised postmortem and imaged using the IVIS Spectrum. All animal experiments were performed in an AAALAC approved facility using protocols approved by the Albert Einstein College of Medicine Animal Usage Committee.
